Related Experiment Video
Updated: May 19, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Microsatellite instability in colorectal cancer
1University Medical Centre Maribor, Maribor, Slovenia.
Radiology and Oncology
|August 31, 2012
Summary
Microsatellite instability (MSI-H) is crucial in colorectal cancer (CRC) development and treatment. Further research is needed to understand its role in predicting chemotherapy effectiveness for personalized cancer care.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) is a global health concern, with 85% arising from chromosomal instability (CIN) and 15% from microsatellite instability (MSI-H).
- MSI-H is often linked to damaged DNA mismatch repair (MMR) mechanisms, involving key proteins like MSH2, MLH1, and MSH6.
- Hereditary nonpolyposis colorectal cancer (HNPCC) accounts for 10-20% of CRC cases and is associated with MSI-H.
Purpose of the Study:
- To investigate the role of microsatellite instability (MSI-H) as a prognostic and predictive factor in colorectal cancer (CRC).
- To explore the potential of MSI-H in guiding individualized cancer therapy.
- To address the need for further research due to contradictory findings in current clinical trials.
Main Methods:
- Analysis of microsatellite sequences (MS) in normal and cancer cells to determine microsatellite stability (MSS) or instability (MSI-H).
- Evaluation of mismatch repair (MMR) gene status (MSH2, MLH1, MSH6).
- Review of existing clinical trial data regarding MSI-H status and treatment outcomes.
Main Results:
- MSI-H is identified as a significant factor influencing prognosis in colorectal cancer.
- The predictive value of MSI-H in chemotherapy efficacy shows varied results across different treatment settings (adjuvant and palliative).
- Contradictory findings necessitate further investigation into MSI-H's precise role in CRC treatment response.
Conclusions:
- MSI-H is a critical molecular marker in colorectal cancer, impacting both patient prognosis and treatment response.
- Individualized therapy, tailored to molecular tumor characteristics like MSI-H, represents the future of cancer treatment.
- Further clinical trials are essential to clarify the prognostic and predictive significance of MSI-H in CRC.
Related Concept Videos
02:17Microtubule Instability
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...